256 related articles for article (PubMed ID: 21743001)
21. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
22. Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice.
Ponnoth DS; Nayeem MA; Kunduri SS; Tilley SL; Zeldin DC; Ledent C; Mustafa SJ
Am J Physiol Regul Integr Comp Physiol; 2012 Feb; 302(4):R400-8. PubMed ID: 22160543
[TBL] [Abstract][Full Text] [Related]
23. Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
Gazoni LM; Walters DM; Unger EB; Linden J; Kron IL; Laubach VE
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):440-6. PubMed ID: 20398911
[TBL] [Abstract][Full Text] [Related]
24. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
Vessey DA; Li L; Kelley M
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H881-7. PubMed ID: 21685263
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.
Glover DK; Ruiz M; Takehana K; Petruzella FD; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3164-71. PubMed ID: 17308004
[TBL] [Abstract][Full Text] [Related]
26. Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor.
Maas JE; Wan TC; Figler RA; Gross GJ; Auchampach JA
J Mol Cell Cardiol; 2010 Nov; 49(5):886-93. PubMed ID: 20797398
[TBL] [Abstract][Full Text] [Related]
27. Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.
Puri N; Mohey V; Singh M; Kaur T; Pathak D; Buttar HS; Singh AP
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):361-8. PubMed ID: 26728617
[TBL] [Abstract][Full Text] [Related]
28. Adenosine 2B Receptor Activation Reduces Myocardial Reperfusion Injury by Promoting Anti-Inflammatory Macrophages Differentiation via PI3K/Akt Pathway.
Tian Y; Piras BA; Kron IL; French BA; Yang Z
Oxid Med Cell Longev; 2015; 2015():585297. PubMed ID: 26161239
[TBL] [Abstract][Full Text] [Related]
29. Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?
McIntosh VJ; Lasley RD
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):21-33. PubMed ID: 21335481
[TBL] [Abstract][Full Text] [Related]
30. AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts.
Liu Y; Yang X; Yang XM; Walker S; Förster K; Cohen MV; Krieg T; Downey JM
Basic Res Cardiol; 2010 Jan; 105(1):129-37. PubMed ID: 19730798
[TBL] [Abstract][Full Text] [Related]
31. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
[TBL] [Abstract][Full Text] [Related]
32. The effect of two selective A
Cooper SL; March J; Sabbatini AR; Hill SJ; Jörg M; Scammells PJ; Woolard J
Br J Pharmacol; 2020 Jan; 177(2):346-359. PubMed ID: 31596949
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
[TBL] [Abstract][Full Text] [Related]
35. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Zhao T; Xi L; Chelliah J; Levasseur JE; Kukreja RC
Circulation; 2000 Aug; 102(8):902-7. PubMed ID: 10952960
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery.
Teng B; Ledent C; Mustafa SJ
J Mol Cell Cardiol; 2008 May; 44(5):905-14. PubMed ID: 18423660
[TBL] [Abstract][Full Text] [Related]
37. Adenosine improves recovery of postischemic myocardial function via an adenosine A1 receptor mechanism.
Lasley RD; Mentzer RM
Am J Physiol; 1992 Nov; 263(5 Pt 2):H1460-5. PubMed ID: 1443199
[TBL] [Abstract][Full Text] [Related]
38. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
[TBL] [Abstract][Full Text] [Related]
39. Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction.
Zhu Z; Hofmann PA; Buolamwini JK
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2921-6. PubMed ID: 17293492
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion.
Kuno A; Critz SD; Cui L; Solodushko V; Yang XM; Krahn T; Albrecht B; Philipp S; Cohen MV; Downey JM
J Mol Cell Cardiol; 2007 Sep; 43(3):262-71. PubMed ID: 17632123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]